Health Care: Drugs

Halozyme Therapeutics Inc. (HALO: NASDAQ)

$7.57 0.02 | 0.26%
04/17/14 - 04:00 PM ET
TheStreet Ratings Grade for HALO
BuyHoldSell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F

TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.

Click here to find out about our methodology.

Analyst Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 2 2 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.40 2.40 2.50 2.50

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter